These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 18789607)

  • 21. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
    Sabichi AL; Subbarayan V; Llansa N; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1704-9. PubMed ID: 15533896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.
    Valentiner U; Carlsson M; Erttmann R; Hildebrandt H; Schumacher U
    Toxicology; 2005 Sep; 213(1-2):157-68. PubMed ID: 16009482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
    Chintharlapalli S; Papineni S; Safe S
    Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC
    Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
    Coyle AT; O'Keeffe MB; Kinsella BT
    FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
    Ibabe A; Herrero A; Cajaraville MP
    Toxicol In Vitro; 2005 Sep; 19(6):725-35. PubMed ID: 15964169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
    Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C; Liu H; Posch MG; Waechter M; Facklam M; Fenner MH; Ruthardt M; Possinger K; Phillip Koeffler H; Elstner E
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.